These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
166 related articles for article (PubMed ID: 36797677)
21. Mucosal carcinoma of the fallopian tube coexists with ovarian cancer of serous subtype only: a study of Japanese cases. Maeda D; Ota S; Takazawa Y; Ohashi K; Mori M; Imamura T; Nakagawa S; Yano T; Taketani Y; Fukayama M Virchows Arch; 2010 Nov; 457(5):597-608. PubMed ID: 20872013 [TBL] [Abstract][Full Text] [Related]
22. Serous tubal intraepithelial carcinoma localizes to the tubal-peritoneal junction: a pivotal clue to the site of origin of extrauterine high-grade serous carcinoma (ovarian cancer). Seidman JD Int J Gynecol Pathol; 2015 Mar; 34(2):112-20. PubMed ID: 25675178 [TBL] [Abstract][Full Text] [Related]
23. Evaluation of the fallopian tubes after neoadjuvant chemotherapy: persistence of serous tubal intraepithelial carcinoma. Colón E; Carlson JW Int J Gynecol Pathol; 2014 Sep; 33(5):463-9. PubMed ID: 25083961 [TBL] [Abstract][Full Text] [Related]
24. [Expansion of secretory cells in the fallopian tubal epithelium in the early stages of the pathogenesis of ovarian serous carcinomas]. Asaturova AV; Ezhova LS; Faizullina NM; Adamyan LV; Khabas GN; Sannikova MV Arkh Patol; 2017; 79(3):10-18. PubMed ID: 28631711 [TBL] [Abstract][Full Text] [Related]
25. Clinically occult tubal and ovarian high-grade serous carcinomas presenting in uterine samples: diagnostic pitfalls and clues to improve recognition of tumor origin. Bagby C; Ronnett BM; Yemelyanova A; Maleki Z; Kuhn E; Vang R Int J Gynecol Pathol; 2013 Sep; 32(5):433-43. PubMed ID: 23896706 [TBL] [Abstract][Full Text] [Related]
26. Increase of fallopian tube and decrease of ovarian carcinoma: fact or fake? Höhn AK; Klagges S; Gläser A; Taubenheim S; Dornhöfer N; Einenkel J; Hiller GGR; Brambs CE; Horn LC J Cancer Res Clin Oncol; 2021 Mar; 147(3):911-925. PubMed ID: 32915262 [TBL] [Abstract][Full Text] [Related]
27. Early detection of high-grade tubal serous carcinoma in women at low risk for hereditary breast and ovarian cancer syndrome by systematic examination of fallopian tubes incidentally removed during benign surgery. Rabban JT; Garg K; Crawford B; Chen LM; Zaloudek CJ Am J Surg Pathol; 2014 Jun; 38(6):729-42. PubMed ID: 24820399 [TBL] [Abstract][Full Text] [Related]
28. The fallopian tube as the origin of high grade serous ovarian cancer: review of a paradigm shift. Reade CJ; McVey RM; Tone AA; Finlayson SJ; McAlpine JN; Fung-Kee-Fung M; Ferguson SE J Obstet Gynaecol Can; 2014 Feb; 36(2):133-140. PubMed ID: 24518912 [TBL] [Abstract][Full Text] [Related]
29. [Current FIGO staging classification for cancer of ovary, fallopian tube and peritoneum]. Šišovská I; Minář L; Felsinger M; Anton M; Bednaříková M; Hausnerová J; Jandáková E; Weinberger V Ceska Gynekol; 2017; 82(3):230-236. PubMed ID: 28593778 [TBL] [Abstract][Full Text] [Related]
30. Prophylactic salpingectomy and prophylactic salpingoophorectomy for adnexal high-grade serous epithelial carcinoma: A reappraisal. Oliver Perez MR; Magriñá J; García AT; Jiménez Lopez JS Surg Oncol; 2015 Dec; 24(4):335-44. PubMed ID: 26690823 [TBL] [Abstract][Full Text] [Related]
31. Multi-modal Profiling of the Extracellular Matrix of Human Fallopian Tubes and Serous Tubal Intraepithelial Carcinomas. Renner C; Gomez C; Visetsouk MR; Taha I; Khan A; McGregor SM; Weisman P; Naba A; Masters KS; Kreeger PK J Histochem Cytochem; 2022 Feb; 70(2):151-168. PubMed ID: 34866441 [TBL] [Abstract][Full Text] [Related]
32. Trends in the incidence of serous fallopian tube, ovarian, and peritoneal cancer in the US. Liao CI; Chow S; Chen LM; Kapp DS; Mann A; Chan JK Gynecol Oncol; 2018 May; 149(2):318-323. PubMed ID: 29514737 [TBL] [Abstract][Full Text] [Related]
33. A case of primary peritoneal carcinoma: evidence for a precursor in the fallopian tube. Nasser S; Arsenic R; Lohneis P; Kosian P; Sehouli J Anticancer Res; 2014 Jan; 34(1):407-12. PubMed ID: 24403495 [TBL] [Abstract][Full Text] [Related]
34. Incidence of germline BRCA1/2 mutations in women with tubo-ovarian high-grade serous carcinomas with and without serous tubal intra-epithelial carcinomas. Dowson CB; Stewart C; O'Sullivan S; Pachter N; Schofield L; Cohen PA Int J Gynecol Cancer; 2020 Jan; 30(1):94-99. PubMed ID: 31699802 [TBL] [Abstract][Full Text] [Related]
35. [Preliminary study on the relationship between tubal intraepithelial carcinoma of the fimbria and pelvic high-grade serous carcinoma]. Liang Y; Chen XD; Lü BJ; Zhou CY; Zhang XF; Shi HY Zhonghua Fu Chan Ke Za Zhi; 2011 Oct; 46(10):724-8. PubMed ID: 22321343 [TBL] [Abstract][Full Text] [Related]
36. Chromosomal instability in fallopian tube precursor lesions of serous carcinoma and frequent monoclonality of synchronous ovarian and fallopian tube mucosal serous carcinoma. Salvador S; Rempel A; Soslow RA; Gilks B; Huntsman D; Miller D Gynecol Oncol; 2008 Sep; 110(3):408-17. PubMed ID: 18597838 [TBL] [Abstract][Full Text] [Related]
37. Pathology of the Fallopian Tube: Tubal Involvement by Ovarian Tumors and Incidental Findings in the Nontumoral Setting. Karpathiou G; Chauleur C; Venet M; Clemenson A; Peoc'h M Pathobiology; 2020; 87(1):37-44. PubMed ID: 31972564 [TBL] [Abstract][Full Text] [Related]